Literature DB >> 5032717

Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol.

E Wolinsky, F Gomez, F Zimpfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5032717     DOI： 10.1164/arrd.1972.105.6.964

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  9 in total

1.  Cutaneous nontuberculous mycobacterial infections.

Authors:  B J Bendl; R C Ongley
Journal:  Can Fam Physician       Date:  1978-03       Impact factor: 3.275

2.  Serum agglutinins in disease caused by Mycobacterium intracellulare.

Authors:  D J Dawson; E W Abrahams; Z M Blacklock
Journal:  Appl Microbiol       Date:  1974-06

Review 3.  Mycobacterium marinum infections in man.

Authors:  C H Collins; J M Grange; W C Noble; M D Yates
Journal:  J Hyg (Lond)       Date:  1985-04

Review 4.  Mycobacterium.

Authors:  L Barksdale; K S Kim
Journal:  Bacteriol Rev       Date:  1977-03

5.  In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents.

Authors:  W J Sanders; E Wolinsky
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

6.  Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.

Authors:  L B Heifets; M D Iseman; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

7.  Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.

Authors:  M S Stone; R J Wallace; J M Swenson; C Thornsberry; L A Christensen
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

8.  Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides.

Authors:  R J Wallace; K Wiss
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

9.  Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.

Authors:  Kelly M Pennington; Ann Vu; Douglas Challener; Christina G Rivera; F N U Shweta; John D Zeuli; Zelalem Temesgen
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.